CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Wang also acknowledges emerging platforms such as CAR NK cells and in vivo CAR T technologies but notes these remain ...

Gujarat is leading India's solar cell manufacturing with significant investments and capacity expansions, positioning itself ...

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

Reliance Industries has paused its battery manufacturing plans after failing to acquire Chinese cell technology, highlighting ...

The production of red blood cells from stem cells has emerged as a transformative approach to address chronic blood shortages and meet the increasing demand for transfusion therapies. By harnessing ...